DUBLIN, Ohio, May 27, 2015 /PRNewswire/ -- Later this
week, Cardinal Health Specialty Solutions will present a new series
of health economic outcomes research (HEOR) studies that reinforce
the importance of evaluating real-world treatment patterns when
developing value-based reimbursement strategies.
Dr. Bruce Feinberg, vice
president and chief medical officer of Cardinal Health Specialty
Solutions, says that physicians, payers and pharmaceutical
companies alike have known for more than a decade that clinical
trials alone do not accurately reflect how cancer treatment happens
in the real world. Feinberg maintains that payers are seeing this
disparity, and are adjusting reimbursement strategies as a
result.
"With an increased focus on value-based care, which relies on
real-world clinical evidence, clinical trial data no longer
provides enough information to develop appropriate reimbursement
models," said Feinberg. "This new research reinforces that HEOR
data can help payers better understand the effectiveness of
treatments in real-world settings; and that it can be used to
better determine value-based reimbursement strategies."
Over the past year, Cardinal Health Specialty Solutions has
published numerous studies on real-world treatment patterns in
leukemia and lymphoma care; and the economic impact of that care on
patients. Building upon this body of work, Cardinal Health
Specialty Solutions will publish a new set of clinical studies
focused on renal cell carcinoma at the American Society of Clinical
Oncology (ASCO) meeting May 29- June 2,
2015 in Chicago.
To view full abstracts of the company's research being featured
at the 2015 ASCO Annual Meeting, click here. Attendees of the ASCO
Annual Meeting can also learn more by visiting Cardinal Health
Specialty Solutions' booth #4041 at the 2015 ASCO Annual
Meeting.
About Cardinal Health Specialty Solutions
Cardinal Health Specialty Solutions provides clinical,
reimbursement, technology and distribution services that help
health care professionals, payers and pharmaceutical and biotech
companies improve the quality and cost-effectiveness of caring for
patients who are managing complex diseases. Cardinal Health
Specialty Solutions helps customers alleviate day-to-day
administrative burdens, optimize business functions and partner to
implement new innovations that move their businesses forward.
To learn more, visit www.cardinalhealth.com/specialtysolutions.
About Cardinal Health
Headquartered in Dublin, Ohio,
Cardinal Health, Inc. (NYSE: CAH) is a $91 billion health care services
company that improves the cost-effectiveness of health care.
As the business behind health care, Cardinal Health helps
pharmacies, hospitals, ambulatory surgery centers,
clinical laboratories and physician offices focus on
patient care while reducing costs, enhancing efficiency and
improving quality. Cardinal Health is an essential link in the
health care supply chain,
providing pharmaceuticals and medical
products and services to more than 100,000 locations each day
and is also the industry-leading direct-to-home medical supplies
distributor. The company is a leading manufacturer of medical and
surgical products, including gloves, surgical
apparel and fluid management products. In addition,
the company operates the nation's largest network of
radiopharmacies that dispense products to aid in the early
diagnosis and treatment of disease. Ranked #22 on the Fortune 500,
Cardinal Health employs 34,000 people worldwide. More
information about the company may be found
at www.cardinalhealth.com and @CardinalHealth on
Twitter.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/new-studies-reinforce-important-role-real-world-patient-data-can-play-in-developing-value-based-reimbursement-strategies-300089336.html
SOURCE Cardinal Health